Charlier D, Roovers M, Gigot D, Huysveld N, Piérard A, Glansdorff N
Research Institute, CERIA-COOVI, Brussels, Belgium.
Mol Gen Genet. 1993 Feb;237(1-2):273-86. doi: 10.1007/BF00282809.
We report the identification of Integration Host Factor (IHF) as a new element involved in modulation of P1, the upstream pyrimidine-specific promoter of the Escherichia coli K12 and Salmonella typhimurium carAB operons. Band-shift assays, performed with S-30 extracts of the wild type and a himA, hip double mutant or with purified IHF demonstrate that, in vitro, this factor binds to a region 300 bp upstream of the transcription initiation site of P1 in both organisms. This was confirmed by deletion analysis of the target site. DNase I, hydroxyl radical and dimethylsulphate footprinting experiments allowed us to allocate the IHF binding site to a 38 bp, highly A+T-rich stretch, centred around nucleotide -305 upstream of the transcription initiation site. Protein-DNA contacts are apparently spread over a large number of bases and are mainly located in the minor groove of the helix. Measurements of carbamoyl-phosphate synthetase (CPSase) and beta-galactosidase specific activities from car-lacZ fusion constructs of wild type or IHF target site mutants introduced into several genetic backgrounds affected in the himA gene or in the pyrimidine-mediated control of P1 (carP6 or pyrH+/-), or in both, indicate that, in vivo, IHF influences P1 activity as well as its control by pyrimidines. IHF stimulates P1 promoter activity in minimal medium, but increases the repressibility of this promoter by pyrimidines. These antagonistic effects result in a two- to threefold reduction in the repressibility of promoter P1 by pyrimidines in the absence of IHF binding. IHF thus appears to be required for maximal expression as well as for establishment of full repression. IHF could exert this function by modulating the binding of a pyrimidine-specific regulatory molecule.
我们报告了整合宿主因子(IHF)的鉴定,它是参与调节大肠杆菌K12和鼠伤寒沙门氏菌carAB操纵子上游嘧啶特异性启动子P1的一个新元件。用野生型和himA、hip双突变体的S-30提取物或纯化的IHF进行的凝胶迁移试验表明,在体外,该因子在两种生物体中均与P1转录起始位点上游300 bp的区域结合。通过对靶位点的缺失分析证实了这一点。DNA酶I、羟自由基和硫酸二甲酯足迹实验使我们能够将IHF结合位点定位到一个38 bp、富含A+T的区域,该区域以转录起始位点上游核苷酸-305为中心。蛋白质与DNA的接触显然分布在大量碱基上,并且主要位于螺旋的小沟中。对野生型或IHF靶位点突变体的car-lacZ融合构建体的氨甲酰磷酸合成酶(CPSase)和β-半乳糖苷酶比活性的测量,这些构建体被引入到在himA基因或嘧啶介导的P1调控(carP6或pyrH+/-)或两者中受到影响的几种遗传背景中,结果表明,在体内,IHF影响P1活性及其受嘧啶的调控。在基本培养基中,IHF刺激P1启动子活性,但增加该启动子受嘧啶的抑制性。这些拮抗作用导致在没有IHF结合的情况下,P1启动子受嘧啶的抑制性降低两到三倍。因此,IHF似乎是最大表达以及完全抑制建立所必需的。IHF可能通过调节嘧啶特异性调节分子的结合来发挥这一功能。